Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loretta J Nastoupil

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Current Hematologic Malignancy Reports|April 2, 2021
When to Use Targeted Therapy for the Treatment of Follicular LymphomaLoretta J Nastoupil
Clinical Advances in Hematology & Oncology : H&O|August 2, 2018
Recent insights into large granular lymphocytic leukemiaLoretta J Nastoupil
Clinical Advances in Hematology & Oncology : H&O|November 22, 2021
The evolving use of CAR T-cell therapy in follicular lymphomaLoretta J Nastoupil
Oncology (Williston Park, N.Y.)|August 29, 2018
Point: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?Loretta J Nastoupil
Blood|October 6, 2018
Next-generation therapy for follicular lymphomaLoretta J Nastoupil
Nature Reviews. Clinical Oncology|February 5, 2026
Beyond the R² horizon: new triplet regimens for relapsed and/or refractory follicular lymphomaLoretta J Nastoupil
Oncology (Williston Park, N.Y.)|September 17, 2014
Routine use of maintenance therapy in follicular lymphoma: the strategy is effective, raising the question, 'what is the most important measure of success in the current era?'Loretta J Nastoupil
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Real-World Experiences of CAR T-Cell Therapy for Large B-Cell Lymphoma: How Similar Are They to the Prospective Studies?Kevin Tang, Loretta J Nastoupil
Current Oncology Reports|May 20, 2015
Novel immunologic approaches in lymphoma: unleashing the brakes on the immune systemLoretta J Nastoupil, Sattva S Neelapu
Cancer|July 8, 2015
Identifying racial differences in nodular lymphocyte-predominant Hodgkin lymphomaChristopher R Flowers, Loretta J Nastoupil
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Current Hematologic Malignancy Reports|April 2, 2021
When to Use Targeted Therapy for the Treatment of Follicular LymphomaLoretta J Nastoupil
Clinical Advances in Hematology & Oncology : H&O|August 2, 2018
Recent insights into large granular lymphocytic leukemiaLoretta J Nastoupil
Clinical Advances in Hematology & Oncology : H&O|November 22, 2021
The evolving use of CAR T-cell therapy in follicular lymphomaLoretta J Nastoupil
Oncology (Williston Park, N.Y.)|August 29, 2018
Point: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?Loretta J Nastoupil
Blood|October 6, 2018
Next-generation therapy for follicular lymphomaLoretta J Nastoupil
Nature Reviews. Clinical Oncology|February 5, 2026
Beyond the R² horizon: new triplet regimens for relapsed and/or refractory follicular lymphomaLoretta J Nastoupil
Oncology (Williston Park, N.Y.)|September 17, 2014
Routine use of maintenance therapy in follicular lymphoma: the strategy is effective, raising the question, 'what is the most important measure of success in the current era?'Loretta J Nastoupil
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Real-World Experiences of CAR T-Cell Therapy for Large B-Cell Lymphoma: How Similar Are They to the Prospective Studies?Kevin Tang, Loretta J Nastoupil
Current Oncology Reports|May 20, 2015
Novel immunologic approaches in lymphoma: unleashing the brakes on the immune systemLoretta J Nastoupil, Sattva S Neelapu
Cancer|July 8, 2015
Identifying racial differences in nodular lymphocyte-predominant Hodgkin lymphomaChristopher R Flowers, Loretta J Nastoupil
Pageof 21